H. Wolf

435 total citations
14 papers, 242 citations indexed

About

H. Wolf is a scholar working on Oncology, Infectious Diseases and Surgery. According to data from OpenAlex, H. Wolf has authored 14 papers receiving a total of 242 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 3 papers in Infectious Diseases and 3 papers in Surgery. Recurrent topics in H. Wolf's work include Neutropenia and Cancer Infections (4 papers), COVID-19 Clinical Research Studies (2 papers) and Blood disorders and treatments (2 papers). H. Wolf is often cited by papers focused on Neutropenia and Cancer Infections (4 papers), COVID-19 Clinical Research Studies (2 papers) and Blood disorders and treatments (2 papers). H. Wolf collaborates with scholars based in Germany, United States and Switzerland. H. Wolf's co-authors include Wieland Voigt, Hans‐Joachim Schmoll, Dirk Arnold, Karin Jordan, Axel Hinke, Axel Grothey, Marcus Hentrich, Marie von Lilienfeld‐Toal, Hans Salwender and Helmut Ostermann and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and European Journal of Cancer.

In The Last Decade

H. Wolf

13 papers receiving 233 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H. Wolf Germany 7 104 68 45 41 38 14 242
Sumiko Kohashi Japan 9 53 0.5× 16 0.2× 47 1.0× 17 0.4× 49 1.3× 29 252
Antonio Franco Spain 11 79 0.8× 94 1.4× 47 1.0× 6 0.1× 14 0.4× 42 398
Yuta Matsukuma Japan 10 30 0.3× 57 0.8× 15 0.3× 13 0.3× 44 1.2× 42 259
Aris Tsalouchos Italy 9 23 0.2× 82 1.2× 33 0.7× 13 0.3× 14 0.4× 35 249
Ala Alkhatib United States 8 63 0.6× 29 0.4× 95 2.1× 50 1.2× 40 1.1× 11 316
G. R. Youngs United Kingdom 11 84 0.8× 153 2.3× 14 0.3× 5 0.1× 17 0.4× 18 330
Charlotte Colosio France 9 38 0.4× 49 0.7× 42 0.9× 10 0.2× 11 0.3× 18 254
Samar Harris United States 8 48 0.5× 95 1.4× 22 0.5× 12 0.3× 8 0.2× 25 200
Rubén Fernández-Álvarez Spain 6 67 0.6× 14 0.2× 20 0.4× 19 0.5× 10 0.3× 11 171
Tiphaine Vidal-Trécan France 10 135 1.3× 59 0.9× 31 0.7× 31 0.8× 9 0.2× 23 323

Countries citing papers authored by H. Wolf

Since Specialization
Citations

This map shows the geographic impact of H. Wolf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Wolf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Wolf more than expected).

Fields of papers citing papers by H. Wolf

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Wolf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Wolf. The network helps show where H. Wolf may publish in the future.

Co-authorship network of co-authors of H. Wolf

This figure shows the co-authorship network connecting the top 25 collaborators of H. Wolf. A scholar is included among the top collaborators of H. Wolf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Wolf. H. Wolf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Giesen, Nicola, Rosanne Sprute, Maria Madeleine Rüthrich, et al.. (2021). 2021 update of the AGIHO guideline on evidence-based management of COVID-19 in patients with cancer regarding diagnostics, viral shedding, vaccination and therapy. European Journal of Cancer. 147. 154–160. 31 indexed citations
2.
Giesen, Nicola, Rosanne Sprute, Maria Madeleine Rüthrich, et al.. (2020). Evidence-based management of COVID-19 in cancer patients: Guideline by the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO). European Journal of Cancer. 140. 86–104. 20 indexed citations
3.
Wolf, H., et al.. (2015). Characterization of monoclonal gammopathy in patients with amyotrophic lateral sclerosis. Acta Neurologica Scandinavica. 132(3). 212–215.
4.
5.
Jordan, Karin, H. Wolf, Wieland Voigt, et al.. (2010). Bevacizumab in combination with sequential high-dose chemotherapy in solid cancer, a feasibility study. Bone Marrow Transplantation. 45(12). 1704–1709. 6 indexed citations
6.
Penack, Olaf, Dieter Buchheidt, Maximilian Christopeit, et al.. (2010). Management of sepsis in neutropenic patients: guidelines from the infectious diseases working party of the German Society of Hematology and Oncology. Annals of Oncology. 22(5). 1019–1029. 42 indexed citations
7.
8.
Jordan, Karin, Axel Hinke, Axel Grothey, et al.. (2007). A meta-analysis comparing the efficacy of four 5-HT3-receptor antagonists for acute chemotherapy-induced emesis. Supportive Care in Cancer. 15(9). 1023–1033. 69 indexed citations
9.
Kröger, Nicolaus, Oleg Gluz, Svjetlana Mohrmann, et al.. (2006). Randomized Trial of Single Compared With Tandem High-Dose Chemotherapy Followed by Autologous Stem-Cell Transplantation in Patients With Chemotherapy-Sensitive Metastatic Breast Cancer. Journal of Clinical Oncology. 24(24). 3919–3926. 10 indexed citations
10.
Paulsen, Frank, Claus Belka, Wilfried Budach, et al.. (2000). Cystosarcoma phyllodes malignum: a case report of a successive triple modality treatment. International Journal of Hyperthermia. 16(4). 319–324. 1 indexed citations
11.
Karthaus, Meinolf, H. Wolf, Gerlinde Egerer, et al.. (1998). Ceftriaxone Monotherapy in the Treatment of Low-Risk Febrile Neutropenia. Chemotherapy. 44(5). 343–354. 19 indexed citations
12.
Karthaus, Meinolf, H. Wolf, Gerlinde Egerer, et al.. (1998). Ceftriaxone in the Treatment of Solid Tumour Patients with Febrile Neutropenia. Oncology Research and Treatment. 21(3). 212–216. 4 indexed citations
13.
Wolf, H., et al.. (1984). [Transurethral ultrasonography of newly discovered bladder tumors].. PubMed. 146(8). 583–5. 2 indexed citations
14.
Löhr, H & H. Wolf. (1978). Viszerale Kala-Azar-Erkrankung beim Kind*. DMW - Deutsche Medizinische Wochenschrift. 103(10). 424–427. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sumiko Kohashi Breakdown of academic impact, for papers by Antonio Franco Breakdown of academic impact, for papers by Yuta Matsukuma Breakdown of academic impact, for papers by Aris Tsalouchos Breakdown of academic impact, for papers by Ala Alkhatib Breakdown of academic impact, for papers by G. R. Youngs Breakdown of academic impact, for papers by Charlotte Colosio Breakdown of academic impact, for papers by Samar Harris Breakdown of academic impact, for papers by Rubén Fernández-Álvarez Breakdown of academic impact, for papers by Tiphaine Vidal-Trécan
Rankless by CCL
2026